{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:52:34Z","timestamp":1792446754597,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Bipolar Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Given the likelihood of progressive illness in bipolar disorder (BD), it is important to understand the benefits and risks of interventions administered early in illness course. We conducted a systematic review of the effectiveness of interventions in the early course of BD I or II.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We completed a systematic search on MEDLINE, PsycINFO, EMBASE, the Cochrane Central Register of Controlled Trials, CINAHL and Google Scholar from 1\/1\/1979 till 14\/9\/2022. We included controlled trials examining intervention effects on symptomatic, course, functional and tolerability outcomes of patients in the \u2018early course\u2019 of BD I or II. We classified patients to be in early course if they (a) were seeking help for the first time for a manic episode, (b) had a lifetime history of up to 3 manic episodes, or (c) had up to 6 lifetime mood episodes. Evidence quality was assessed using the GRADE approach.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>From 4135 unique publications we included 25 reports representing 2212 participants in 16 randomized studies, and 17,714 participants from nine non-randomized studies. Available evidence suggested that in early illness course, lithium use was associated with lower recurrence risk compared with other mood stabilizers. Mood stabilizers were also associated with better global functioning, compared with the use of antipsychotics in the medium term. While summative findings regarding psychological therapies were limited by heterogeneity, family-focused and cognitive-behavioral interventions were associated with reduced recurrence risk or improved symptomatic outcomes. There was some evidence that the same pharmacological interventions were more efficacious in preventing recurrences when utilized in earlier rather than later illness course.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions and recommendations<\/jats:title>\n                <jats:p>While there are promising initial findings, there is a need for more adequately powered trials to examine the efficacy and tolerability of interventions in youth and adults in early illness course. Specifically, there is a compelling need to compare the relative benefits of lithium with other pharmacological agents in preventing recurrences. In addition to symptomatic outcomes, there should be a greater focus on functional impact and tolerability. Effective pharmacological and psychological interventions should be offered to those in early course of BD, balancing potential risks using shared decision-making approaches.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40345-022-00275-3","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T14:04:07Z","timestamp":1672754647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["A systematic review of interventions in the early course of bipolar disorder I or II: a report of the International Society for Bipolar Disorders Taskforce on early intervention"],"prefix":"10.1186","volume":"11","author":[{"given":"A.","family":"Ratheesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ramain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Conus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Fristad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hillegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jauhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. V.","family":"Kessing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"Miklowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. N.","family":"Yatham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Marwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"issue":"1\u20133","key":"275_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jad.2007.01.027","volume":"103","author":"M Berk","year":"2007","unstructured":"Berk M, Dodd S, Callaly P, et al. History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder. J Affect Disord. 2007;103(1\u20133):181\u20136.","journal-title":"J Affect Disord"},{"issue":"3","key":"275_CR2","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","volume":"35","author":"M Berk","year":"2009","unstructured":"Berk M, Kapczinski F, Andreazza AC, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2009;35(3):804\u201317.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"275_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1399-5618.2011.00889.x","volume":"13","author":"M Berk","year":"2011","unstructured":"Berk M, Brnabic A, Dodd S, et al. Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord. 2011;13(1):87\u201398.","journal-title":"Bipolar Disord"},{"key":"275_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/1741-7015-11-162","volume":"11","author":"L Berk","year":"2013","unstructured":"Berk L, Berk M, Dodd S, Kelly C, Cvetkovski S, Jorm AF. Evaluation of the acceptability and usefulness of an information website for caregivers of people with bipolar disorder. BMC Med. 2013;11:162.","journal-title":"BMC Med"},{"issue":"6","key":"275_CR5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1192\/bjp.bp.116.186833","volume":"210","author":"M Berk","year":"2017","unstructured":"Berk M, Daglas R, Dandash O, et al. Quetiapine v lithium in the maintenance phase following a first episode of mania: randomised controlled trial. Br J Psychiatry. 2017;210(6):413\u201321.","journal-title":"Br J Psychiatry"},{"issue":"33","key":"275_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1192\/S0007125000297663","volume":"172","author":"M Birchwood","year":"1998","unstructured":"Birchwood M, Todd P, Jackson C. Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry Suppl. 1998;172(33):53\u20139.","journal-title":"Br J Psychiatry Suppl"},{"issue":"4","key":"275_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/bdi.13016","volume":"23","author":"S Bolton","year":"2021","unstructured":"Bolton S, Warner J, Harriss E, Geddes J, Saunders KEA. Bipolar disorder: trimodal age-at-onset distribution. Bipolar Disord. 2021;23(4):341\u201356.","journal-title":"Bipolar Disord"},{"issue":"5","key":"275_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/hrp.11.5.245.256","volume":"11","author":"IM Bratti","year":"2003","unstructured":"Bratti IM, Baldessarini RJ, Baethge C, Tondo L. Pretreatment episode count and response to lithium treatment in manic-depressive illness. Harv Rev Psychiatry. 2003;11(5):245\u201356.","journal-title":"Harv Rev Psychiatry"},{"issue":"2","key":"275_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s00127-005-0864-7","volume":"40","author":"EJ Bromet","year":"2005","unstructured":"Bromet EJ, Finch SJ, Carlson GA, et al. Time to remission and relapse after the first hospital admission in severe bipolar disorder. Soc Psychiatry Psychiatr Epidemiol. 2005;40(2):106\u201313.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"275_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l6890","volume":"368","author":"M Campbell","year":"2020","unstructured":"Campbell M, McKenzie JE, Sowden A, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020;368: l6890.","journal-title":"BMJ"},{"key":"275_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyu079","author":"AF Carvalho","year":"2014","unstructured":"Carvalho AF, Quevedo J, McIntyre RS, et al. Treatment implications of predominant polarity and the polarity index: a comprehensive review. Int J Neuropsychopharmacol. 2014. https:\/\/doi.org\/10.1093\/ijnp\/pyu079.","journal-title":"Int J Neuropsychopharmacol."},{"issue":"4","key":"275_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.3221","volume":"3","author":"A Caspi","year":"2020","unstructured":"Caspi A, Houts RM, Ambler A, et al. Longitudinal assessment of mental health disorders and comorbidities across 4 decades among participants in the dunedin birth cohort study. JAMA Netw Open. 2020;3(4): e203221.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"275_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1601-5215.2010.00450.x","volume":"22","author":"F Colom","year":"2010","unstructured":"Colom F, Reinares M, Pacchiarotti I, et al. Has number of previous episodes any effect on response to group psychoeducation in bipolar patients? A 5-year follow-up post hoc analysis. Acta Neuropsychiatr. 2010a;22(2):50\u20133.","journal-title":"Acta Neuropsychiatr"},{"key":"275_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1601-5215.2010.00450.x","volume":"22","author":"F Colom","year":"2010","unstructured":"Colom F, Reinares M, Pacchiarotti I, et al. Has number of previous episodes any effect on response to group psychoeducation in bipolar patients? A 5-year follow-up post hoc analysis. Acta Neuropsychiatrica. 2010b;22:50\u20133.","journal-title":"Acta Neuropsychiatrica"},{"issue":"5","key":"275_CR15","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/bdi.12137","volume":"16","author":"P Conus","year":"2014","unstructured":"Conus P, Macneil C, McGorry PD. Public health significance of bipolar disorder: implications for early intervention and prevention. Bipolar Disord. 2014;16(5):548\u201356.","journal-title":"Bipolar Disord"},{"issue":"8","key":"275_CR16","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.eurpsy.2015.09.009","volume":"30","author":"P Conus","year":"2015","unstructured":"Conus P, Berk M, Cotton SM, et al. Olanzapine or chlorpromazine plus lithium in first episode psychotic mania: an 8-week randomised controlled trial. Eur Psychiatry. 2015;30(8):975\u201382.","journal-title":"Eur Psychiatry"},{"issue":"6","key":"275_CR17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1001\/jamapsychiatry.2018.0623","volume":"75","author":"CU Correll","year":"2018","unstructured":"Correll CU, Galling B, Pawar A, et al. Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression. JAMA Psychiat. 2018;75(6):555\u201365.","journal-title":"JAMA Psychiat"},{"issue":"5","key":"275_CR18","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1399-5618.2004.00142.x","volume":"6","author":"TJ Craig","year":"2004","unstructured":"Craig TJ, Grossman S, Mojtabai R, et al. Medication use patterns and 2-year outcome in first-admission bipolar disorder with psychotic features. Bipolar Disord. 2004;6(5):406\u201315.","journal-title":"Bipolar Disord"},{"issue":"3","key":"275_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jaac.2014.12.012","volume":"54","author":"HC Detke","year":"2015","unstructured":"Detke HC, DelBello MP, Landry J, Usher RW. Olanzapine\/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2015;54(3):217\u201324.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"275_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jphysparis.2013.03.006","volume":"107","author":"PA Geoffroy","year":"2013","unstructured":"Geoffroy PA, Etain B, Scott J, et al. Reconsideration of bipolar disorder as a developmental disorder: importance of the time of onset. J Physiol Paris. 2013;107(4):278\u201385.","journal-title":"J Physiol Paris"},{"issue":"7","key":"275_CR21","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/bdi.12556","volume":"19","author":"BI Goldstein","year":"2017","unstructured":"Goldstein BI, Birmaher B, Carlson GA, et al. The International Society for Bipolar Disorders Task Force report on pediatric bipolar disorder: knowledge to date and directions for future research. Bipolar Disord. 2017;19(7):524\u201343.","journal-title":"Bipolar Disord"},{"issue":"6","key":"275_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1177\/0269881116636545","volume":"30","author":"GM Goodwin","year":"2016","unstructured":"Goodwin GM, Haddad PM, Ferrier IN, et al. Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2016;30(6):495\u2013553.","journal-title":"J Psychopharmacol."},{"issue":"2","key":"275_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/15622970902823202","volume":"10","author":"H Grunze","year":"2009","unstructured":"Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry. 2009;10(2):85\u2013116.","journal-title":"World J Biol Psychiatry"},{"issue":"2","key":"275_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/15622970903555881","volume":"11","author":"H Grunze","year":"2010","unstructured":"Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry. 2010;11(2):81\u2013109.","journal-title":"World J Biol Psychiatry"},{"issue":"3","key":"275_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3109\/15622975.2013.770551","volume":"14","author":"H Grunze","year":"2013","unstructured":"Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013;14(3):154\u2013219.","journal-title":"World J Biol Psychiatry"},{"issue":"7650","key":"275_CR26","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136.","journal-title":"BMJ"},{"issue":"10","key":"275_CR27","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.jaac.2019.06.013","volume":"59","author":"DM Hafeman","year":"2020","unstructured":"Hafeman DM, Rooks B, Merranko J, et al. Lithium versus other mood-stabilizing medications in a longitudinal study of youth diagnosed with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2020;59(10):1146\u201355.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"275_CR28","first-page":"300","volume":"71","author":"RJ Haggerty","year":"1994","unstructured":"Haggerty RJ, Mrazek PJ. Can we prevent mental illness? Bull N Y Acad Med. 1994;71(2):300\u20136.","journal-title":"Bull N Y Acad Med"},{"key":"275_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, et al. The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343: d5928.","journal-title":"BMJ"},{"issue":"2","key":"275_CR30","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/acps.13062","volume":"140","author":"TP Hui","year":"2019","unstructured":"Hui TP, Kandola A, Shen L, et al. A systematic review and meta-analysis of clinical predictors of lithium response in bipolar disorder. Acta Psychiatr Scand. 2019;140(2):94\u2013115.","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"275_CR31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/bdi.12273","volume":"17","author":"ML Inder","year":"2015","unstructured":"Inder ML, Crowe MT, Luty SE, et al. Randomized, controlled trial of interpersonal and social rhythm therapy for young people with bipolar disorder. Bipolar Disord. 2015;17(2):128\u201338.","journal-title":"Bipolar Disord"},{"issue":"1","key":"275_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40345-019-0145-0","volume":"7","author":"S Jauhar","year":"2019","unstructured":"Jauhar S, Young AH. Controversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy. Int J Bipolar Disord. 2019;7(1):10.","journal-title":"Int J Bipolar Disord"},{"issue":"10","key":"275_CR33","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S2215-0366(19)30082-3","volume":"6","author":"S Jauhar","year":"2019","unstructured":"Jauhar S, Ratheesh A, Davey C, et al. The case for improved care and provision of treatment for people with first-episode mania. Lancet Psychiatry. 2019;6(10):869\u201376.","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"275_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1192\/bjp.bp.110.084822","volume":"199","author":"LV Kessing","year":"2011","unstructured":"Kessing LV, Hellmund G, Geddes JR, Goodwin GM, Andersen PK. Valproate v lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study. Br J Psychiatry J Ment Sci. 2011;199(1):57\u201363.","journal-title":"Br J Psychiatry J Ment Sci."},{"issue":"5","key":"275_CR35","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1177\/0269881111414091","volume":"26","author":"LV Kessing","year":"2012","unstructured":"Kessing LV, Hellmund G, Andersen PK. An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder. J Psychopharmacol. 2012;26(5):644\u201352.","journal-title":"J Psychopharmacol"},{"issue":"3","key":"275_CR36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1192\/bjp.bp.112.113548","volume":"202","author":"LV Kessing","year":"2013","unstructured":"Kessing LV, Hansen HV, Hvenegaard A, et al. Treatment in a specialised out-patient mood disorder clinic v standard out-patient treatment in the early course of bipolar disorder: randomised clinical trial. Br J Psychiatry. 2013;202(3):212\u20139.","journal-title":"Br J Psychiatry"},{"key":"275_CR37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jad.2013.10.001","volume":"152\u2013154","author":"LV Kessing","year":"2014","unstructured":"Kessing LV, Hansen HV, Christensen EM, Dam H, Gluud C, Wetterslev J. Do young adults with bipolar disorder benefit from early intervention? J Affect Disord. 2014a;152\u2013154:403\u20138.","journal-title":"J Affect Disord"},{"issue":"3","key":"275_CR38","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1192\/bjp.bp.113.142802","volume":"205","author":"LV Kessing","year":"2014","unstructured":"Kessing LV, Vradi E, Andersen PK. Starting lithium prophylaxis early v late in bipolar disorder. Br J Psychiatry. 2014b;205(3):214\u201320.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"275_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4088\/JCP.v67n0113","volume":"67","author":"TA Ketter","year":"2006","unstructured":"Ketter TA, Houston JP, Adams DH, et al. Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes. J Clin Psychiatry. 2006;67(1):95\u2013101.","journal-title":"J Clin Psychiatry"},{"key":"275_CR40","doi-asserted-by":"crossref","unstructured":"Kupka R, Duffy A, Scott J, et al. Consensus on nomenclature for clinical staging models in bipolar disorder: a narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force. Bipolar Disord. 2021.","DOI":"10.1111\/bdi.13105"},{"key":"275_CR41","first-page":"48","volume":"1","author":"GS Leverich","year":"1996","unstructured":"Leverich GS, Post RM. Life charting the course of bipolar disorder. Curr Rev Mood Anxiety Disord. 1996;1:48\u201361.","journal-title":"Curr Rev Mood Anxiety Disord"},{"issue":"2","key":"275_CR42","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1176\/appi.ajp.163.2.240","volume":"163","author":"PI Lin","year":"2006","unstructured":"Lin PI, McInnis MG, Potash JB, et al. Clinical correlates and familial aggregation of age at onset in bipolar disorder. Am J Psychiatry. 2006;163(2):240\u20136.","journal-title":"Am J Psychiatry"},{"issue":"6","key":"275_CR43","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.genhosppsych.2013.07.002","volume":"35","author":"JJ Liu","year":"2013","unstructured":"Liu JJ, Norman RM, Manchanda R, De Luca V. Admixture analysis of age at onset in schizophrenia: evidence of three subgroups in a first-episode sample. Gen Hosp Psychiatry. 2013;35(6):664\u20137.","journal-title":"Gen Hosp Psychiatry"},{"issue":"4","key":"275_CR44","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1751-7893.2011.00336.x","volume":"6","author":"CA Macneil","year":"2012","unstructured":"Macneil CA, Hasty M, Cotton S, et al. Can a targeted psychological intervention be effective for young people following a first manic episode? Results from an 18-month pilot study. Early Interv Psychiatry. 2012;6(4):380\u20138.","journal-title":"Early Interv Psychiatry"},{"issue":"8","key":"275_CR45","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/bdi.12576","volume":"19","author":"GS Malhi","year":"2017","unstructured":"Malhi GS, Morris G, Hamilton A, Outhred T, Mannie Z. Is, \u201cearly intervention\u201d in bipolar disorder what it claims to be? Bipolar Disord. 2017;19(8):627\u201336.","journal-title":"Bipolar Disord"},{"issue":"1","key":"275_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/0004867420979353","volume":"55","author":"GS Malhi","year":"2021","unstructured":"Malhi GS, Bell E, Bassett D, et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry. 2021;55(1):7\u2013117.","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"275_CR47","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1600-0447.1986.tb02668.x","volume":"73","author":"AJ Mander","year":"1986","unstructured":"Mander AJ. Is lithium justified after one manic episode? Acta Psychiatr Scand. 1986;73(1):60\u20137.","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"275_CR48","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/acps.12087","volume":"128","author":"S Marwaha","year":"2013","unstructured":"Marwaha S, Durrani A, Singh S. Employment outcomes in people with bipolar disorder: a systematic review. Acta Psychiatr Scand. 2013;128(3):179\u201393.","journal-title":"Acta Psychiatr Scand"},{"issue":"9","key":"275_CR49","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1001\/archpsyc.60.9.904","volume":"60","author":"DJ Miklowitz","year":"2003","unstructured":"Miklowitz DJ, George EL, Richards JA, Simoneau TL, Suddath RL. A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Arch Gen Psychiatry. 2003;60(9):904\u201312.","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"275_CR50","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1001\/archpsyc.65.9.1053","volume":"65","author":"DJ Miklowitz","year":"2008","unstructured":"Miklowitz DJ, Axelson DA, Birmaher B, et al. Family-focused treatment for adolescents with bipolar disorder: results of a 2-year randomized trial. Arch Gen Psychiatry. 2008;65(9):1053\u201361.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"275_CR51","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1176\/appi.ajp.2014.13081130","volume":"171","author":"DJ Miklowitz","year":"2014","unstructured":"Miklowitz DJ, Schneck CD, George EL, et al. Pharmacotherapy and family-focused treatment for adolescents with bipolar I and II disorders: a 2-year randomized trial. Am J Psychiatry. 2014;171(6):658\u201367.","journal-title":"Am J Psychiatry"},{"issue":"10","key":"275_CR52","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/sim.2022","volume":"24","author":"SA Murphy","year":"2005","unstructured":"Murphy SA. An experimental design for the development of adaptive treatment strategies. Stat Med. 2005;24(10):1455\u201381.","journal-title":"Stat Med"},{"issue":"12","key":"275_CR53","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jaac.2016.09.498","volume":"55","author":"A Neumann","year":"2016","unstructured":"Neumann A, Pappa I, Lahey BB, et al. Single nucleotide polymorphism heritability of a general psychopathology factor in children. J Am Acad Child Adolesc Psychiatry. 2016;55(12):1038-1045 e1034.","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"key":"275_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.","journal-title":"BMJ"},{"issue":"7","key":"275_CR55","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1089\/cap.2021.0039","volume":"31","author":"LR Patino","year":"2021","unstructured":"Patino LR, Klein CC, Strawn JR, et al. A randomized, double-blind, controlled trial of lithium versus quetiapine for the treatment of acute mania in youth with early course bipolar disorder. J Child Adolesc Psychopharmacol. 2021;31(7):485\u201393.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"7177","key":"275_CR56","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/bmj.318.7177.149","volume":"318","author":"A Perry","year":"1999","unstructured":"Perry A, Tarrier N, Morriss R, McCarthy E, Limb K. Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. BMJ. 1999;318(7177):149\u201353.","journal-title":"BMJ"},{"issue":"16","key":"275_CR57","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1017\/S0033291714000804","volume":"44","author":"A Peters","year":"2014","unstructured":"Peters A, Sylvia LG, da Silva Magalh\u00e3es PV, et al. Age at onset, course of illness and response to psychotherapy in bipolar disorder: results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Psychol Med. 2014;44(16):3455\u201367.","journal-title":"Psychol Med"},{"issue":"2","key":"275_CR58","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1192\/bjp.bp.107.037820","volume":"192","author":"RM Post","year":"2008","unstructured":"Post RM, Luckenbaugh DA, Leverich GS, et al. Incidence of childhood-onset bipolar illness in the USA and Europe. Br J Psychiatry. 2008;192(2):150\u20131.","journal-title":"Br J Psychiatry"},{"issue":"11","key":"275_CR59","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/S0006-3223(03)00165-3","volume":"53","author":"GS Sachs","year":"2003","unstructured":"Sachs GS, Thase ME, Otto MW, et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2003;53(11):1028\u201342.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"275_CR60","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S2215-0366(20)30188-7","volume":"8","author":"G Saraf","year":"2021","unstructured":"Saraf G, Moazen-Zadeh E, Pinto JV, et al. Early intervention for people at high risk of developing bipolar disorder: a systematic review of clinical trials. Lancet Psychiatry. 2021;8(1):64\u201375.","journal-title":"Lancet Psychiatry"},{"key":"275_CR61","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1192\/bjp.188.4.313","volume":"188","author":"J Scott","year":"2006","unstructured":"Scott J, Paykel E, Morriss R, et al. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry J Ment Sci. 2006;188:313\u201320.","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"275_CR62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40345-014-0015-8","volume":"2","author":"E Severus","year":"2014","unstructured":"Severus E, Taylor MJ, Sauer C, et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord. 2014;2:15.","journal-title":"Int J Bipolar Disord"},{"key":"275_CR63","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291721002026","author":"KSO Sletved","year":"2021","unstructured":"Sletved KSO, Ziersen SC, Andersen PK, Vinberg M, Kessing LV. Socio-economic functioning in patients with bipolar disorder and their unaffected siblings\u2014results from a nation-wide population-based longitudinal study. Psychol Med. 2021. https:\/\/doi.org\/10.1017\/S0033291721002026.","journal-title":"Psychol Med"},{"key":"275_CR64","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hernan MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355: i4919.","journal-title":"BMJ"},{"issue":"6","key":"275_CR65","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/bdi.12426","volume":"18","author":"SM Strakowski","year":"2016","unstructured":"Strakowski SM, Fleck DE, Welge J, et al. fMRI brain activation changes following treatment of a first bipolar manic episode. Bipolar Disord. 2016;18(6):490\u2013501.","journal-title":"Bipolar Disord"},{"issue":"8","key":"275_CR66","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1176\/ajp.156.8.1264","volume":"156","author":"AC Swann","year":"1999","unstructured":"Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry. 1999;156(8):1264\u20136.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"275_CR67","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1176\/ajp.151.1.130","volume":"151","author":"M Tohen","year":"1994","unstructured":"Tohen M, Shulman KI, Satlin A. First-episode mania in late life. Am J Psychiatry. 1994;151(1):130\u20132.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"275_CR68","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/bdi.12872","volume":"22","author":"H Tremain","year":"2020","unstructured":"Tremain H, Fletcher K, Murray G. Number of episodes in bipolar disorder: the case for more thoughtful conceptualization and measurement. Bipolar Disord. 2020;22(3):231\u201344.","journal-title":"Bipolar Disord"},{"issue":"5","key":"275_CR69","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1176\/appi.ajp.2017.17090972","volume":"175","author":"E Vieta","year":"2018","unstructured":"Vieta E, Salagre E, Grande I, et al. Early intervention in bipolar disorder. Am J Psychiatry. 2018;175(5):411\u201326.","journal-title":"Am J Psychiatry"},{"issue":"9904","key":"275_CR70","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","volume":"382","author":"HA Whiteford","year":"2013","unstructured":"Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575\u201386.","journal-title":"Lancet"},{"issue":"8","key":"275_CR71","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/mp.2015.158","volume":"21","author":"LN Yatham","year":"2016","unstructured":"Yatham LN, Beaulieu S, Schaffer A, et al. Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: a CANMAT randomized double-blind trial. Mol Psychiatry. 2016;21(8):1050\u20136.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"275_CR72","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/bdi.12609","volume":"20","author":"LN Yatham","year":"2018","unstructured":"Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97\u2013170.","journal-title":"Bipolar Disord"}],"container-title":["International Journal of Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40345-022-00275-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40345-022-00275-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40345-022-00275-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T15:08:57Z","timestamp":1672758537000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalbipolardisorders.springeropen.com\/articles\/10.1186\/s40345-022-00275-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["275"],"URL":"https:\/\/doi.org\/10.1186\/s40345-022-00275-3","relation":{},"ISSN":["2194-7511"],"issn-type":[{"value":"2194-7511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,3]]},"assertion":[{"value":"22 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MB is supported by a NHMRC Senior Principal Research Fellowship (1156072). MB has received Grant\/Research Support from the NIH, Cooperative Research Centre, Simons Autism Foundation, Cancer Council of Victoria, Stanley Medical Research Foundation, Medical Benefits Fund, National Health and Medical Research Council, Medical Research Futures Fund, Beyond Blue, Rotary Health, A2 milk company, Meat and Livestock Board, Woolworths, Avant and the Harry Windsor Foundation, has been a speaker for Abbot, Astra Zeneca, Janssen and Janssen, Lundbeck and Merck and served as a consultant to Allergan, Astra Zeneca, Bioadvantex, Bionomics, Collaborative Medicinal Development, Eisai, Janssen and Janssen, Lundbeck Merck, Pfizer and Servier\u2014all unrelated to this work. LVK has within recent three years been a consultant for Teva and Lundbeck. SJ has received speaker fees for educational talks given for Jannsen, Lundbeck and Sunovian. MT was an employee of Lilly (1997 to 2008) and has received honoraria from or consulted for Abbott, Abvvie, AstraZeneca, Alkermes, Allergan, Bristol Myers Squibb, GlaxoSmithKline, Lilly, Johnson & Johnson, Otsuka, Merck, Gedeon Richter Plc, Sunovion, Intracellular Therapies, Forest, Roche, Elan, Lundbeck, Teva, Pamlab, Minerva, Neurocrine, Pfizer, and Wiley Publishing; his spouse was a full time employee at Lilly (1998\u20132013). DJM receives research support from the NIMH, the Danny Alberts Foundation, Attias Family Foundation, Carl and Roberta Deutsch Foundation, Kayne Family Foundation, AIM for Mental Health, and Max Gray Fund; and book royalties from Guilford Press and John Wiley and Sons. MAF receives royalties from American Psychiatric Publishing and Guilford Press, research support from Janssen, and an editorial stipend from the Society of Clinical Child and Adolescent Psychology. AY has been paid for lectures and advisory boards for the following companies with drugs used in affective and related disorders: Astrazenaca, Eli Lilly, Lundbeck, Sunovion, Servier, Livanova, Janssen, Allegan, Bionomics, Sumitomo Dainippon Pharma, COMPASS, Sage, Novartis. He has been a consultant for Johnson & Johnson and Livanova. He has received honoraria for attending advisory boards and presenting talks at meetings organised by LivaNova, and has been the principal Investigator in the Restore-Life VNS registry study funded by LivaNova. He has also been a principal or chief Investigator on ESKETINTRD3004, Novartis MDD study MIJ821A12201, and trials on psilocybin. He has received grant funding (past and present) from: NIMH (USA); CIHR (Canada); NARSAD (USA); Stanley Medical Research Institute (USA); MRC (UK); Wellcome Trust (UK); Royal College of Physicians (Edin); BMA (UK); UBC-VGH Foundation (Canada); WEDC (Canada); CCS Depression Research Fund (Canada); MSFHR (Canada); NIHR (UK). Janssen (UK). He has no shareholdings in pharmaceutical companies. Professor Young\u2019s independent research is funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King\u2019s College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. AR is supported by an NHMRC (Australia) Early Career Fellowship. The other authors have no conflicts to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}